Skip to main content

Table 3 Unwanted effects of bitter melon and glibenclamide observed during the study period

From: Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients

  Group I (n= 30) Group II (n= 31) Group III (n= 29)
Gastrointestinal tract
Hyperacidity/Heart burn 3 (9.3) 5 (15.1) 1 (3.4)
Anorexia 5 (16.6) 5 (15.1) 3 (10.3)
Nausea 2 (6.6) 3 (9.6) 1 (3.4)
Diarrhoea 1 (3.3) 2 (6.4) -
Appetite 2 (6.6) 5 (16.1) 3 (10.3)
Abdominal discomfort 1 (3.3) 1 (3.2) -
Central Nervous System
Headache 4 (13.3) 9 (29) 5 (17.2)
Dizziness 2 (6.6) 1 (3.20 2 (6.8)
Dermatological
Skin rashes - 2 (6.4) 1 (3.4)